253 related articles for article (PubMed ID: 12122371)
21. Interstitial nephritis in children with Crohn's disease.
Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V
Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141
[No Abstract] [Full Text] [Related]
22. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
Delgado J; Delgado B; Sztarkier I; Cagnano E; Sperber AD; Fich A
Isr Med Assoc J; 2003 Dec; 5(12):897-8. PubMed ID: 14689766
[No Abstract] [Full Text] [Related]
23. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
24. [Mesalazine is without clinical effect in patients with Crohn disease].
Munck LK
Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804
[No Abstract] [Full Text] [Related]
25. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
[TBL] [Abstract][Full Text] [Related]
26. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
Tsuboi R; Matsumoto S; Miyatani H; Mashima H
Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
[TBL] [Abstract][Full Text] [Related]
27. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
Netzer P
Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
[TBL] [Abstract][Full Text] [Related]
28. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease.
Amankonah TD; Strom CB; Vierling JM; Petrovic LM
Am J Gastroenterol; 2001 Aug; 96(8):2520-2. PubMed ID: 11513216
[No Abstract] [Full Text] [Related]
30. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
Ford AC
Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
[No Abstract] [Full Text] [Related]
31. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Moum B
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
[TBL] [Abstract][Full Text] [Related]
32. [Association between membranous glomerulonephritis and Crohn's disease].
Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
[TBL] [Abstract][Full Text] [Related]
33. Severe myalgia associated with mesalazine treatment in a child with Crohn's disease.
Persić M; Palcevski G; Slavić I; Vlahović-Palcevski V
Eur J Clin Pharmacol; 2007 Mar; 63(3):315-7. PubMed ID: 17242922
[No Abstract] [Full Text] [Related]
34. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
[TBL] [Abstract][Full Text] [Related]
35. Mesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.
Galvão Braga C; Martins J; Arantes C; Ramos V; Vieira C; Salgado A; Magalhães S; Correia A
Rev Port Cardiol; 2013 Sep; 32(9):717-20. PubMed ID: 23993290
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
Reinisch W; Stange EF;
Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
[No Abstract] [Full Text] [Related]
37. You're the flight surgeon. Crohn's disease.
Hartwich SA
Aviat Space Environ Med; 2004 Aug; 75(8):716-7. PubMed ID: 15328792
[No Abstract] [Full Text] [Related]
38. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
39. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
40. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Prantera C; Bellinvia S
Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]